Miocamycin is a macrolide type antimicrobial A176170. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia L5737. It has shown to be effective against several gram-positive and gram-negative microbes and may be useful in the treatment of upper and lower respiratory tract infections, and urogenital tract infections or as an alternative to erythromycin treatment A176170.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Alfentanil | The serum concentration of Alfentanil can be increased when it is combined with Miocamycin. |
| Alprazolam | The serum concentration of Alprazolam can be increased when it is combined with Miocamycin. |
| Buspirone | The metabolism of Buspirone can be decreased when combined with Miocamycin. |
| Carbamazepine | The metabolism of Carbamazepine can be decreased when combined with Miocamycin. |
| Cisapride | The serum concentration of Cisapride can be increased when it is combined with Miocamycin. |
| Disopyramide | Miocamycin may increase the QTc-prolonging activities of Disopyramide. |
| Estazolam | The serum concentration of Estazolam can be increased when it is combined with Miocamycin. |
| Midazolam | The serum concentration of Midazolam can be increased when it is combined with Miocamycin. |
| Quinine | The serum concentration of Quinine can be increased when it is combined with Miocamycin. |
| Quinidine | The serum concentration of Quinidine can be increased when it is combined with Miocamycin. |
| Repaglinide | The serum concentration of Repaglinide can be increased when it is combined with Miocamycin. |
| Sirolimus | The metabolism of Sirolimus can be decreased when combined with Miocamycin. |
| Temsirolimus | The metabolism of Temsirolimus can be decreased when combined with Miocamycin. |
| Terfenadine | The serum concentration of Terfenadine can be increased when it is combined with Miocamycin. |
| Triazolam | The serum concentration of Triazolam can be increased when it is combined with Miocamycin. |
| Telaprevir | The serum concentration of Telaprevir can be increased when it is combined with Miocamycin. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Miocamycin. |
| Vintafolide | The serum concentration of Vintafolide can be increased when it is combined with Miocamycin. |
| Vincamine | The serum concentration of Vincamine can be increased when it is combined with Miocamycin. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be increased when it is combined with Miocamycin. |
| Deslanoside | The serum concentration of Deslanoside can be increased when it is combined with Miocamycin. |
| Ouabain | The serum concentration of Ouabain can be increased when it is combined with Miocamycin. |
| Oleandrin | The serum concentration of Oleandrin can be increased when it is combined with Miocamycin. |
| Cymarin | The serum concentration of Cymarin can be increased when it is combined with Miocamycin. |
| Proscillaridin | The serum concentration of Proscillaridin can be increased when it is combined with Miocamycin. |
| Metildigoxin | The serum concentration of Metildigoxin can be increased when it is combined with Miocamycin. |
| Lanatoside C | The serum concentration of Lanatoside C can be increased when it is combined with Miocamycin. |
| Gitoformate | The serum concentration of Gitoformate can be increased when it is combined with Miocamycin. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be increased when it is combined with Miocamycin. |
| Peruvoside | The serum concentration of Peruvoside can be increased when it is combined with Miocamycin. |
| Cyclosporine | The metabolism of Cyclosporine can be decreased when combined with Miocamycin. |
| Tacrolimus | The serum concentration of Tacrolimus can be increased when it is combined with Miocamycin. |
| Dicoumarol | The serum concentration of Dicoumarol can be increased when it is combined with Miocamycin. |
| Phenindione | The serum concentration of Phenindione can be increased when it is combined with Miocamycin. |
| Coumarin | The serum concentration of Coumarin can be increased when it is combined with Miocamycin. |
| Tioclomarol | The serum concentration of Tioclomarol can be increased when it is combined with Miocamycin. |
| Ethyl biscoumacetate | The serum concentration of Ethyl biscoumacetate can be increased when it is combined with Miocamycin. |
| Diphenadione | The serum concentration of Diphenadione can be increased when it is combined with Miocamycin. |
| 4-hydroxycoumarin | The serum concentration of 4-hydroxycoumarin can be increased when it is combined with Miocamycin. |
| Fluindione | The serum concentration of Fluindione can be increased when it is combined with Miocamycin. |
| Clorindione | The serum concentration of Clorindione can be increased when it is combined with Miocamycin. |
| Oxtriphylline | The metabolism of Oxtriphylline can be decreased when combined with Miocamycin. |
| Doxofylline | The metabolism of Doxofylline can be decreased when combined with Miocamycin. |
| Bamifylline | The metabolism of Bamifylline can be decreased when combined with Miocamycin. |
| Acefylline | The metabolism of Acefylline can be decreased when combined with Miocamycin. |
| Bufylline | The metabolism of Bufylline can be decreased when combined with Miocamycin. |
| Fenethylline | The metabolism of Fenethylline can be decreased when combined with Miocamycin. |
| Proxyphylline | The metabolism of Proxyphylline can be decreased when combined with Miocamycin. |
| Bromotheophylline | The metabolism of Bromotheophylline can be decreased when combined with Miocamycin. |
| Pentoxifylline | The metabolism of Pentoxifylline can be decreased when combined with Miocamycin. |
| 8-azaguanine | The metabolism of 8-azaguanine can be decreased when combined with Miocamycin. |
| 7,9-Dimethylguanine | The metabolism of 7,9-Dimethylguanine can be decreased when combined with Miocamycin. |
| Xanthine | The metabolism of Xanthine can be decreased when combined with Miocamycin. |
| 7-Deazaguanine | The metabolism of 7-Deazaguanine can be decreased when combined with Miocamycin. |
| Guanine | The metabolism of Guanine can be decreased when combined with Miocamycin. |
| 9-Methylguanine | The metabolism of 9-Methylguanine can be decreased when combined with Miocamycin. |
| Peldesine | The metabolism of Peldesine can be decreased when combined with Miocamycin. |
| Hypoxanthine | The metabolism of Hypoxanthine can be decreased when combined with Miocamycin. |
| 9-Deazaguanine | The metabolism of 9-Deazaguanine can be decreased when combined with Miocamycin. |
| Valomaciclovir | The metabolism of Valomaciclovir can be decreased when combined with Miocamycin. |
| 3-isobutyl-1-methyl-7H-xanthine | The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Miocamycin. |
| Uric acid | The metabolism of Uric acid can be decreased when combined with Miocamycin. |
| 6-O-benzylguanine | The metabolism of 6-O-benzylguanine can be decreased when combined with Miocamycin. |
| Lisofylline | The metabolism of Lisofylline can be decreased when combined with Miocamycin. |
| Lobucavir | The metabolism of Lobucavir can be decreased when combined with Miocamycin. |
| Cafedrine | The metabolism of Cafedrine can be decreased when combined with Miocamycin. |
| Theodrenaline | The metabolism of Theodrenaline can be decreased when combined with Miocamycin. |
| Etamiphylline | The metabolism of Etamiphylline can be decreased when combined with Miocamycin. |
| Pentifylline | The metabolism of Pentifylline can be decreased when combined with Miocamycin. |
| Furafylline | The metabolism of Furafylline can be decreased when combined with Miocamycin. |
| Theobromine | The metabolism of Theobromine can be decreased when combined with Miocamycin. |
| Propentofylline | The metabolism of Propentofylline can be decreased when combined with Miocamycin. |
| Caffeine | The metabolism of Caffeine can be decreased when combined with Miocamycin. |
| 8-chlorotheophylline | The metabolism of 8-chlorotheophylline can be decreased when combined with Miocamycin. |
| Mercaptopurine | The metabolism of Mercaptopurine can be decreased when combined with Miocamycin. |
| PCS-499 | The metabolism of PCS-499 can be decreased when combined with Miocamycin. |
| Methylergometrine | The serum concentration of Methylergometrine can be increased when it is combined with Miocamycin. |
| Lisuride | The serum concentration of Lisuride can be increased when it is combined with Miocamycin. |
| Nicergoline | The serum concentration of Nicergoline can be increased when it is combined with Miocamycin. |
| Ergoloid mesylate | The serum concentration of Ergoloid mesylate can be increased when it is combined with Miocamycin. |
| Pergolide | The serum concentration of Pergolide can be increased when it is combined with Miocamycin. |
| Ergometrine | The serum concentration of Ergometrine can be increased when it is combined with Miocamycin. |
| Lysergic acid diethylamide | The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Miocamycin. |
| Dihydroergocornine | The serum concentration of Dihydroergocornine can be increased when it is combined with Miocamycin. |
| Dihydroergocristine | The serum concentration of Dihydroergocristine can be increased when it is combined with Miocamycin. |
| Dihydroergocryptine | The serum concentration of Dihydroergocryptine can be increased when it is combined with Miocamycin. |
| Terguride | The serum concentration of Terguride can be increased when it is combined with Miocamycin. |
| Metergoline | The serum concentration of Metergoline can be increased when it is combined with Miocamycin. |
| Methysergide | The serum concentration of Methysergide can be increased when it is combined with Miocamycin. |
| Bromocriptine | The serum concentration of Bromocriptine can be increased when it is combined with Miocamycin. |
| BCG vaccine | The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Miocamycin. |
| Typhoid vaccine | The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Miocamycin. |
| Atorvastatin | The risk or severity of adverse effects can be increased when Miocamycin is combined with Atorvastatin. |
| (R)-warfarin | The serum concentration of (R)-warfarin can be increased when it is combined with Miocamycin. |
| (S)-Warfarin | The serum concentration of (S)-Warfarin can be increased when it is combined with Miocamycin. |
| Azithromycin | The metabolism of Azithromycin can be decreased when combined with Miocamycin. |
| Ziprasidone | The metabolism of Ziprasidone can be decreased when combined with Miocamycin. |
| Chlorpromazine | The metabolism of Chlorpromazine can be decreased when combined with Miocamycin. |
| Albendazole | The metabolism of Albendazole can be decreased when combined with Miocamycin. |
| Cephalexin | The metabolism of Cephalexin can be decreased when combined with Miocamycin. |